CoronaVac efficacy data from Turkey - Authors' reply.

Tanriover, Mine Durusu; Doganay, Hamdi Levent; Unal, Serhat; Akova, Murat

Tanriover, Mine Durusu; Doganay, Hamdi Levent; Unal, Serhat; Akova, Murat.

Afiliación

Tanriover MD; Department of Internal Medicine, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey.
Doganay HL; Department of Gastroenterology, Turkish Republic Ministry of Health, Istanbul Provincial Health Directorate, University of Health Sciences Istanbul Umraniye Training and Research Hospital, Istanbul, Turkey.
Unal S; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey.
Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey. Electronic address: makova@hacettepe.edu.tr.

Lancet ; 398(10314): 1874, 2021 11 20.

Article en En | MEDLINE | ID: mdl-34801106

Asunto(s)

Anticuerpos Neutralizantes; Anticuerpos Antivirales; Humanos; Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Anticuerpos Antivirales Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google